Product Information
TYENNE 162 MG/0.9 ML AUTOINJCT is a brand biologic product labeled by Fresenius Kabi USA, LLC, priced at $820.9968 per ML under NDC 65219059601. Its NADAC has been published 35 times since Dec 24, 2025.
Strength
162 mg/.9mL
Manufacturer
Fresenius Kabi USA, LLCNDC
65219059601
Classification
Brand Biologic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
TOCILIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761449On Market Since
9/1/2025
Pharmacological Classes
Price Statistics
The NADAC for TYENNE 162 MG/0.9 ML AUTOINJCT has been published 35 times since Dec 24, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $820.9968 per ML |
|---|---|
| All-time high | $821.7093 (May 13, 2026) |
| All-time low | $819.6321 (May 20, 2026) |
| 52-week high | $821.7093 |
| 52-week low | $819.6321 |
| Median price | $820.6574 |
| Average price | $820.5074 |
| Largest weekly change | -0.3% (May 20, 2026) |
| Weeks tracked | 35 |
| Tracking since | Dec 24, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TYENNE 162 MG/0.9 ML AUTOINJCT?
The current National Average Drug Acquisition Cost (NADAC) for TYENNE 162 MG/0.9 ML AUTOINJCT, manufactured by Fresenius Kabi USA, LLC, is $820.9968 per ML (NDC 65219059601), effective Aug 19, 2026.
How has the price of TYENNE 162 MG/0.9 ML AUTOINJCT changed over time?
Over the history we have for it, the NADAC for TYENNE 162 MG/0.9 ML AUTOINJCT has held within roughly two percent of its current level. It has been tracked across 35 weekly CMS publications since Dec 24, 2025.
What are the highest and lowest recorded NADAC prices for TYENNE 162 MG/0.9 ML AUTOINJCT?
Since Dec 24, 2025, the NADAC for TYENNE 162 MG/0.9 ML AUTOINJCT has ranged from a low of $819.6321 (May 20, 2026) to a high of $821.7093 (May 13, 2026), with a median of $820.6574 per ML.
Are there cheaper alternatives to TYENNE 162 MG/0.9 ML AUTOINJCT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TYENNE 162 MG/0.9 ML AUTOINJCT in a comparable dosage form, but none are currently priced below it.
Who manufactures TYENNE 162 MG/0.9 ML AUTOINJCT?
TYENNE 162 MG/0.9 ML AUTOINJCT (NDC 65219059601) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a brand biologic product.